Abstract:Sickle cell disease (SCD), a distinctive and often overlooked illness in the 21st century, is a congenital blood disorder characterized by considerable phenotypic diversity. It comprises a group of disorders, with sickle cell anemia (SCA) being the most prevalent and serious genotype. Although there have been some systematic reviews of global data, worldwide statistics regarding SCD prevalence, morbidity, and mortality remain scarce. In developed countries with a lower number of sickle cell patients, cutting-edge technologies have led to the development of new treatments. However, in developing settings where sickle cell disease (SCD) is more prevalent, medical management, rather than a cure, still relies on the use of hydroxyurea, blood transfusions, and analgesics. This is a disease that affects red blood cells, consequently affecting most organs in diverse manners. We discuss its etiology and the advent of new technologies, but the aim of this study is to understand the various types of nutrition-related studies involving individuals suffering from SCD, particularly in Africa. The interplay of the environment, food, gut microbiota, along with their respective genomes collectively known as the gut microbiome, and host metabolism is responsible for mediating host metabolic phenotypes and modulating gut microbiota. In addition, it serves the purpose of providing essential nutrients. Moreover, it engages in direct interactions with host homeostasis and the immune system, as well as indirect interactions via metabolites. Nutrition interventions and nutritional care are mechanisms for addressing increased nutrient expenditures and are important aspects of supportive management for patients with SCD. Underprivileged areas in Sub-Saharan Africa should be accompanied by efforts to define and promote of the nutritional aspects of SCD. Their importance is key to maintaining well-being and quality of life, especially because new technologies and products remain limited, while the use of native medicinal plant resources is acknowledged.

An update review of new therapies in sickle cell disease: the prospects for drug combinations

Newer Modalities and Updates in the Management of Sickle Cell Disease: A Systematic Review

A critical review of therapeutic interventions in sickle cell disease: Progress and challenges

Current and Future Therapeutics for Treating Patients with Sickle Cell Disease

Disease-Modifying Therapies for Sickle Cell Disease—An Overview

Advancing life: innovative approaches to enhance survival in sickle cell anemia patients

Gene Therapies for Sickle Cell Disease

Curative Therapies for Sickle Cell Disease

Clinical Practice Patterns in Sickle Cell Disease Treatment: Disease-modifying and Potentially Curative Therapies

Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions

Sickle Cell Disease: Current Drug Treatments and Functional Foods with Therapeutic Potential

Treating Sickle Cell Disease: Gene Therapy Approaches

Sickle Cell Disease in Brazil: Current Management

Systemic medications for sickle cell disease and potential applications for sickle cell retinopathy

Blood Spotlight Review on Gene Therapy for Sickle Cell Disease

Fostering a healthier generation of children with sickle cell disease through advancements in care

Current state of gene therapy in sickle cell disease

The Role of Non-genetic Therapies to Reduce the Incidence of Sickle Cell Crisis: A Systematic Review

Sickle Cell Disease: From Genetics to Curative Approaches

Novel Therapeutic Approaches In Thalassemias, Sickle Cell Disease And Other Red Cell Disorders

Successes And Pitfalls In Orphan Drug Development For Sickle Cell Disease